Literature DB >> 8219207

Cloning and expression of the cDNA encoding mouse neutrophil gelatinase: demonstration of coordinate secondary granule protein gene expression during terminal neutrophil maturation.

T Graubert1, J Johnston, N Berliner.   

Abstract

The 92-kD form of human type IV collagenase (gelatinase) is a member of the matrix metalloproteinase family. It is restricted in its expression to the granulocytic lineage of white blood cells. Within neutrophils it resides in secondary granules, which are markers of terminal myeloid differentiation. We have isolated and sequenced the cDNA encoding the murine counterpart to the human 92-kD metalloproteinase from a macrophage cDNA library. The human and murine genes are highly homologous and exist in an identical form in neutrophils and monocyte-macrophages in both species. Two polyadenylation signals are present in the murine 3' untranslated sequence, accounting for equal expression of two messenger RNAs. We have shown that expression of gelatinase mRNA is controlled in a coordinate fashion together with lactoferrin, also a component of neutrophil secondary granules, and that this control occurs at the level of transcription. This is the first definitive demonstration of coordinate transcriptional regulation of secondary granule protein gene expression, a feature of normal myelopoiesis that is deranged in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8219207

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.

Authors:  T Betsuyaku; Y Fukuda; W C Parks; J M Shipley; R M Senior
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Representational difference analysis of a committed myeloid progenitor cell line reveals evidence for bilineage potential.

Authors:  N D Lawson; N Berliner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

3.  Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases.

Authors:  A Matsuzaki; A Janowska-Wieczorek
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.

Authors:  S Shiozawa; K Shimizu; K Tanaka; K Hino
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  The multifunctional Ca2+/calmodulin-dependent kinase II regulates vascular smooth muscle migration through matrix metalloproteinase 9.

Authors:  Jason A Scott; Litao Xie; Hui Li; Weiwei Li; Julie B He; Philip N Sanders; A Brent Carter; Johannes Backs; Mark E Anderson; Isabella M Grumbach
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

6.  Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis.

Authors:  R E Swiderski; J E Dencoff; C S Floerchinger; S D Shapiro; G W Hunninghake
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

7.  Thyroid hormone-dependent expression of bullfrog tadpole collagenase gene.

Authors:  Ken Oofusa; Katsutoshi Yoshizato
Journal:  Rouxs Arch Dev Biol       Date:  1996-02

8.  Differentiation and characterization of myeloid cells.

Authors:  Dipti Gupta; Hetavi Parag Shah; Krishnakumar Malu; Nancy Berliner; Peter Gaines
Journal:  Curr Protoc Immunol       Date:  2014-02-04

9.  A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene.

Authors:  M O Lee; Y Liu; X K Zhang
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  Interferon gamma induction of pulmonary emphysema in the adult murine lung.

Authors:  Z Wang; T Zheng; Z Zhu; R J Homer; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.